^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    PSMD1 overexpression

    i
    Other names: PSMD10, Proteasome 26S Subunit Non-ATPase 10, Gankyrin 2, Proteasome (Prosome Macropain) 26S Subunit Non-ATPase 10, 26S Proteasome Non-ATPase Regulatory Subunit 10, 26S Proteasome Regulatory Subunit P28, P28(GANK), P28, Hepatocellular Carcinoma-Associated Protein P28-II, Ankyrin Repeat Protein, DJ889N15.2
    Entrez ID:
    5707
    2years
    PSMD1 as a prognostic marker and potential target in oropharyngeal cancer. (PubMed, BMC Cancer)
    In our study, we established PSMD1 as a negative prognostic factor in oropharyngeal squamous cell carcinoma, indicating its potential as a target for targeted therapy and paving the way for future in vitro studies on drug repositioning.
    Journal
    |
    PSMD1 (Proteasome 26S Subunit Non-ATPase 1)
    |
    PSMD1 overexpression